A Multinational, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Investigate the Efficacy, Safety and Duration of Effect of a Single Administration of Various Doses of Cetrorelix SR in Subjects With Histologically Confirmed Endometriosis

Site 6101, Clayton

Site 6103, Nedlands

Site 6104, Randwick

Site 6102, Sydney

Site 3201, Aalter

Site 3202, Brussels

Site 3203, Leuven

Site 3501, Sofia

Site 3502, Sofia

Site 3503, Sofia

Site 3504, Sofia

Site 3505, Sofia

Site 3506, Sofia

Site 4904, Berlin

Site 4905, Dresden

Site 4903, Heidelberg

Site 4901, Herne

Site 4902, Tübingen

Site 4000, Bucharest

Site 4001, Bucharest

Site 4002, Bucharest

Site 4004, Bucharest

Site 4005, Bucharest

Site 4006, Bucharest

Site 4007, Bucharest

Site 4009, Bucharest

Site 4008, Constanța

Site 4003, Craiova

Site 0701, Moscow

Site 0901, Moscow

Site 0902, Moscow

Site 0903, Moscow

Site 0904, Moscow

Site 0905, Moscow

Site 0906, Moscow

Site 0907, Moscow

Site 0908, Moscow

Site 0909, Moscow

Site 0702, Saint Petersburg

Site 0703, Saint Petersburg

Site 0704, Saint Petersburg

Site 0705, Saint Petersburg

Site 0706, Saint Petersburg

Site 0707, Saint Petersburg

Site 2705, Bloemfontein

Site 2703, Cape Town

Site 2702, Centurion

Site 2701, Roodepoort

Site 2704, Roodepoort

Site 3805, Dnipro

Site 3801, Donetsk

Site 3803, Kiev

Site 3806, Kiev

Site 3807, Kiev

Site 3808, Kiev

Site 3802, Odesa

Site 3804, Zaporizhzhya